You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天壇生物(600161.SH)2020年歸母淨利增4.57%至6.39億元 擬10派1元
格隆匯 04-26 18:15

格隆匯 4 月 26日丨天壇生物(600161.SH)披露2020年年度報吿,報吿期內,公司立足血液製品業務,進一步鞏固血液製品行業領先地位,全年實現營業收入344,559.49萬元,與上年同期相比增長4.99%;實現淨利潤94,307.66萬元,與上年同期相比增長5.46%;實現歸屬於上市公司股東的淨利潤63,900.69萬元,與上年同期相比增4.57%。基本每股收益0.51元。擬向全體股東每10股派發現金股利1元(含税)。

報吿期內,公司持續加大營銷力度,使產品銷售量有所增加,帶來銷售收入增加以及利潤增加;公司通過加強質量管控,強化生產精細化操作,提高產品收率;通過強化控費降本,深入挖潛增效,有效推進提質增效工作;通過深化集中採購,降低採購成本等一系列措施控制生產成本,降低了由於疫情帶來的採漿成本、單位生產成本上升等影響,穩定了產品毛利率。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account